About RadSep, Inc.

Print Friendly, PDF & Email

Purifying Radioisotopes to Save Lives and our Planet
Award winning Molecular Recognition Technology™ (MRT™) is used worldwide in nuclear medicine, nuclear waste clean-up and other applications spanning the periodic table of the elements.

History: IBC Advanced Technologies, Inc.

RadSep, Inc. is a subsidiary of IBC Advanced Technologies, Inc., the global leader in highly selective separations. Founded in the U.S. in 1988, IBC has decades of experience designing, manufacturing and installing MRT™ products and systems for customers worldwide.

View Representative Projects

Expertise: Highly Selective Separations of Radionuclides

MRT™ is based on Nobel prize winning green chemistry and is distinguished by highly selective, high yield first pass recoveries. Over the years, IBC has received numerous commercial contracts for highly selective separations of radioisotopes from a wide range of feed sources.

In addition, IBC is the co-recipient of several prestigious awards, most notably the U.S. DOE Secretary’s Honor Award and the Council for Chemical Research, Collaboration Research Award, for the successful scale-up of an MRT™ radionuclide separation system for the highly selective extraction of cesium-137 from radioactive salt wastes at the U.S. DOE Savannah River Site. IBC has also won multiple awards for its co-development of Empore Rad Disks, which are widely used for environmental monitoring and radiochemical analysis of strontium-90 as well as radium-226 and radium-228. These include the R&D 100 Award and the Federal Laboratory Consortium Award for Excellence in Technology Transfer as well as recognition as a Top 40 R&D 100 Award Winner.

RadSep incorporates the breadth of IBC’s expertise to bring highly selective separations to the radiopharma industry.

See our Partners

Team

RadSep President and CEO
Steven R. Izatt

President and CEO

Director of Organic Synthesis at RadSep
Dr. Krzysztof E. Krakowiak

Director of Organic Synthesis

RadSep Marketing Specialist
Bailey Mortensen

Technical Marketing Specialist

Dr. Robert G. Holmes
Dr. Robert G. G. Holmes

Advisory Board

Advisory Board Member
John Carney

Advisory Board

Partners

RadSep’s expertise is illustrated by the wide range of commercial applications that use MRT™ for highly selective radioisotope separations. Examples of market leaders using MRT™ include:

Orano Med - Ra-228 separation

Orano Med

Ra-228 separation for Pb-212 production

Theragenics Logo

Theragenics

Prostate cancer brachytherapy Pd-103 seed production

DOE Nuclear waste cleaning

US Department of Energy (DOE)

Nuclear waste clean-up of Cs-137 at the Savannah River Site

Fukushima Nuclear Site

Fukushima Nuclear Site

Radioactivity monitoring of Sr-90

Institute for Environmental Sciences, JAEA, and Super Kamiokande

Development of the measurement of Ra-226

Environmental Sciences

Institute for Environmental Sciences

Japan Atomic Energy Agency

JAEA

Super Kamiokande

Super Kamiokande

Join our Mailing List

Be the first to hear about our latest innovations, partnerships and more.

Connect with Us

Follow us on Linkedin

Ibc Advanced Technologies
© 2024 RadSep. All rights reserved

Website by Axxiem

Team

RadSep President and CEO

Steven R. Izatt

President and CEO

With a strong emphasis on chemistry, engineering, manufacturing and customer service, Steve leads IBC’s team to meet the needs of IBC’s worldwide customer base for MRT™ products, processes and services. He is a member of the International Precious Metals Institute (IPMI) and has served on the IPMI Board of Directors. Steve received the IPMI Jun-Ichiro Tanaka Distinguished Achievement Award for entrepreneurial contributions to the precious metals industry. He is a member of the Society of Nuclear Medicine and Molecular Imaging, the European Association of Nuclear Medicine and the American Chemical Society, as well as a Registered Member of the Society for Mining, Metallurgy, and Exploration, satisfying the “Qualified Person (QP)” requirement under Canadian Instrument NI 43-101. Steve holds a B.A. degree (University Scholar, High Honors) in Chemistry from Brigham Young University and two S.M. degrees from the Massachusetts Institute of Technology in Chemical Engineering Practice and in Technology and Policy.

Director of Organic Synthesis at RadSep

Dr. Krzysztof E. Krakowiak

Director of Organic Synthesis

Krzysztof’s expertise is in the design and synthesis of functionalized organic molecules including macrocycles that have unique properties, such as high selectivities for target species including metals and organic molecules. He is particularly adept at the design and development of novel synthetic processes enabling shortening and simplifying of compound preparation for industrial applications. Krzysztof’s skills include the development of improved procedures for preparation of functionalized organic molecules on scales ranging from grams to tonnes for commercial use. His work has been recognized by receipt of numerous awards, including, jointly with Dr. Ronald L. Bruening, the 2020 Industrial Engineering & Chemistry Fellow Award of the American Chemical Society. Dr. Krakowiak received M.Sc. and Ph.D. degrees in Chemistry from the Medical Academy, Lodz, Poland and did postdoctoral work in Organic Chemistry at Brigham Young University.

RadSep Marketing Specialist

Bailey Mortensen

Technical Marketing Specialist

Bailey manages key customer accounts at RadSep with an emphasis on individualized customer service. She also oversees RadSep’s marketing efforts, using her expertise in chemistry, writing and digital tools to encourage the adoption of Molecular Recognition Technology™ as a cleaner, more efficient means of separating individual elements. Bailey holds a B.S. degree in Biochemistry from Brigham Young University.

Dr. Robert G. Holmes

Dr. Robert G. G. Holmes

Advisory Board

Bob is a chemist who studied at Leicester College of Art and Technology, latterly DeMontfort University, for a degree of the Royal Institute of Chemistry (GRIC). He subsequently carried out research for a PhD at the University of Manchester, Institute of Science and Technology and Post-Doctoral Research at the University of York. He then joined British Nuclear Fuels Ltd where he worked on the design of the Thermal Oxide Reprocessing Plant and various waste management facilities. He became the head of BNFL’s Corporate Research Laboratories and in parallel became the Company Chief Scientist. He then transferred to BNFL’s US subsidiary, BNFL Inc., as Chief Technology Officer. This subsidiary was acquired by EnergySolutions where Bob filled the role of Chief Scientist. Bob worked on a bid to run the Chalk River Nuclear Labs, which the consortium submitting the Bid won. Bob joined the team as CNL’s Chief Scientist. Following this placement Bob formed a consultancy, working for several clients including radiopharmaceutical organizations drawing expertise gained at CNL on Mo-99 production and establishing an Ac-225 production project.

Bob has taught at Queens University Belfast and served as Chair of the top tier Waste Management committee at the IAEA.

Bob has 55 years of experience in research and technology in the nuclear and radiochemistry industry.

Advisory Board Member

John Carney

Advisory Board

John entered the Nuclear Medicine industry in 2014 from an orphan drugs background, joining Mallinckrodt’s Nuclear Imaging Division as Finance Director for EMEA and subsequently serving as Vice President, Northern Europe at Mallinckrodt and Curium Pharmaceuticals until July 2018.

Prior to joining Mallinckrodt, John held both General Management and Finance roles with Shire plc including General Manager, Russia and Finance Director, Central Eastern Europe, Middle East and Africa where he was also responsible for managing Distributor relationships in Emerging Markets.

Early in his career, John served for seven years in a wide range of operational and management roles in Cadbury plc and Cadbury Schweppes plc including Finance Director, Europe Supply Chain and Finance Manager, Africa Middle East and Turkey.

John has extensive International experience having worked for over a decade in Europe, Switzerland, Turkey, Russia and Emerging Markets around the world. John started his career with KPMG and is a Chartered Accountant.

John holds an MA and a BA from Oxford University, where he won prize First Class Honours in Modern History at Balliol College. John speaks six languages including French, German, Turkish and Russian.

Share this page

Facebook
Twitter
LinkedIn
Email
.elementor-icon, .elementor-icon-list-icon {display:none!important} #pf-src, .skip-link {display:none!important}